Contributions to COVID-19 Pandemic

  • Sarma P, Prajapat M, Avti P, Kaur H, Kumar S, Medhi B. Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach. Indian J Pharmacol 2020;52:1-5.
  • Manisha Prajapa, Phulen Sarma, Nishant Shekhar, Pramod Avti1, Shweta Sinha2,Hardeep Kaur, Subodh Kumar, Anusuya Bhattacharyya3, Harish Kumar, Seema Bansal, Bikash Medhi. Drug targets for corona virus: A systematic review. Indian J Pharmacol 2020;52:56-65.
  • Phulen Sarma, Nishant Sekhar, Manisha Prajapat, Pramod Avti, Hardeep Kaur, Subodh Kumar, Sanjay Singh, Harish Kumar, Ajay Prakash, Deba Prasad Dhibar, Bikash Medhi. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure & Dynamics (in Press) IF:4.9, Manuscript ID TBSD-2020-0317.
  • Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A, Prajapat M, Shekhar N, Kumar S, Singh R, Singh A, Dhibar DP, Prakash A, Medhi B. Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis. J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25898. [Epub ahead of print] Review.PMID: 32297988.
  • Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A, Prajapat M, Shekhar N, Kumar S, Singh R, Singh A, Dhibar DP, Prakash A, Medhi B. Ocular manifestations and tear or conjunctival swab pcr positivity for 2019-ncov in patients with covid-19: a systematic review and meta-analysis: Lancet (pre-print) 2020.
  • Kaur S, Sarma P, Dhibar DP, Prakash A, Medhi B. Re: Chloroquine and hydroxychloroquine in covid-19. 2020 Apr 27 [cited 2020 Apr 27]; Available from: https://www.bmj.com/content/369/bmj.m1432/rr-27.
  • Anusuya Bhattacharyya, Phulen Sarma, Hardeep Kaur, Bikash Medhi. Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV. Graefe's Archive for Clinical and Experimental Ophthalmology 2020.
  • Vidya M Mahalmani, Dhruv Mahendru, Phulen Sarma, Ajay Prakash, Bikash Medhi. CoVid-19 Pandemic – Hopes Ride High on Targeting Known drugs against Unknow. Ind J Pharmacol 2020;March-April 2020;52(2): 75-78.
  • Vidya M Mahalmani, Dhruv Mahendru, Ankita Semwal, Sukhmeet Kaur, Harpinder Kaur, Phulen Sarma, Ajay Prakash, Bikash MedhI. COVID-19 pandemic: A review based on current evidence. Ind J Pharmacol 2020;March-April 2020;52(2): 117-129.
  • Update on the target structures of SARS-CoV-2: A systematic review. Manisha Prajapat, Phulen Sarma, Nishant Shekhar, Ajay Prakash, Pramod Avti, Anusuya Bhattacharyya, Hardeep Kaur, Subodh Kumar, Seema Bansal, Amit Raj Sharma, Bikash Medhi. 2020;March-April 2020;52(2): 142-
  • Singh R, Singh A, Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A, Prajapat M, Shekhar N, Kumar S, Prakash A, Medhi B A comprehensive review and validation of animal models for Corona Viruses: SARS-CoV2 (Covid-19), SARS-CoV and MERS-CoV
  • Manisha Prajapat1#, Nishant Shekhar1#, Phulen Sarma1#, Pramod Avti1#, Sanjay Singh2, Hardeep Kaur1, Anusuya Bhattacharyya3, Subodh Kumar1, Ajay Prakash1, Bikash Medhi1*. Virtual screening and molecular dynamics of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2: hints towards possibility of repurposing Kanamycin and Folic acid. Journal of Molecular Graphics and Modelling
  • Amit Raj Sharma,Gitika Batra, Singh R, Singh A, Medhi B. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?” Allergologia et Immunopathologia 2020.(Accepted)
  • HCQ-RUD centre study. Indian Journal of Medical Research (IJMR),2020.
  • Immune System Manipulation in Covid-19 Saurabh Sharma, PhD; Phulen Sarma, MD; Manisha Prajapat; Nishant Shekhar; Ajay Prakash, PhD; Bikash Medhi, M.D. Virology (ELS),2020.